Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Nausea 1

Interventions

Dexamethasone 5Calcium Dobesilate 5fosaprepitant 3Ondansetron 3Aprepitant 3dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Palonosetron 2Granisetron 2Cisplatin 2dolasetron 1casopitant 1Surveys and Questionnaires 1Sugars 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Olanzapine 1Neoadjuvant Therapy 1Methadone 1Lorazepam 1Interviews as Topic 1Immunoenzyme Techniques 1Haloperidol 1Esomeprazole 1Diphenhydramine 1Cyproheptadine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Nausea × Haloperidol × Clear all
NCT00124930 2012-01-19

Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

AHS Cancer Control Alberta

Phase 3 Terminated
80 enrolled

Nausea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡